Jimma University   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Jimma Ethiopia (1952)

Organization Overview

First Clinical Trial
2007
NCT00451139
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Facuty of Medical Sciences Jimma University | Jimma University

Active Ingredients

Drugs in Phase 4 Trials (6)

atovaquone (mepron) (1 trial)

coartem (2 trials)

lumefantrine (Coartem) (2 trials)

mebendazole (vermox) (1 trial)

proguanil (1 trial)

quinine (qualaquin) (1 trial)

Drugs in Phase 2 Trials (2)

mmv390048 (1 trial)

primaquine (1 trial)

Drugs in Other Trials (1)

fish oil (Omegavan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 4)

Malaria, Falciparum (Phase 2)

Malaria, Vivax (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 9